Not recruiting
Transgender hormonal therapy
Not recruitingStudy on Cardiovascular Risk Changes After Stopping and Restarting Estradiol in Older Transgender Women on Long-term Hormone Therapy
Registered drugNo placebo
Study on Cardiovascular Risk Changes After Stopping and Restarting Estradiol in Older Transgender Women on Long-term Hormone Therapy
Registered drugNo placebo
- Disease:Transgender hormonal therapy
- Substances:EstradiolEstradiol Valerate
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Estradiol
- Sponsor:Amsterdam UMC Stichting
